Whats new

Whats new.

Jefferies - First LAG-3 Checkpoint Inhibitor Approved (ASX: IMM) (Analyst: Dr David Stanton)

March 19th 2022

For a copy of this analyst report please contact your Jefferies advisor.

Go back